Heart Disease and Diabetes
OUP Oxford, Jul 12, 2012 - Medical - 176 pages
Cardiovascular disease is a common cause of morbidity and mortality in people with diabetes, and it is an issue that is becoming increasingly important to both cardiologists and specialists in diabetes. The routine management of patients with diabetes now includes close attention to the methods to control hyperglycaemia that give maximum reduction in cardiovascular events. This pocketbook details the complications that diabetes presents in relation to heart disease, introduces the reader to various risk factors and discusses the possible treatments that can be explored. This second edition has also been updated throughout to include new trial data, new drugs and updates on treatment of diabetes in heart failure patients. The information in this book is presented in an easy to use format, and supplemented with key figures, tables and summarized research findings.
What people are saying - Write a review
We haven't found any reviews in the usual places.
2 Hyperglycaemia and weight management
3 Diabetic dyslipidaemia
4 Hypertension in diabetes
5 Coronary heart disease in diabetes
6 Acute coronary syndromes in diabetes
7 Coronary revascularization in the patient with diabetes
8 Chronic heart failure in diabetes
Other editions - View all
ACE inhibitors acute coronary syndromes angioplasty aspirin associated atorvastatin autonomic neuropathy benefit beta-blockers blood glucose CABG cardiac cardio cardiovascular death cardiovascular disease cardiovascular outcomes cardiovascular risk CHAPTER 3 Diabetic chronic heart failure clinical clopidogrel compared coronary artery disease coronary heart disease cost-effective Diabetes Study diabetic autonomic neuropathy Diabetic nephropathy diabetic patients drugs dysfunction dyslipidaemia effects endpoint glitazones glycaemic control HbA1c heart rate hyperglycaemia hypertension Hypertension in diabetes impaired increased individuals with diabetes insulin resistance irbesartan ischaemia ischaemic Lancet LDL cholesterol left ventricular lipid losartan lower meta-analysis metabolic syndrome metformin microalbuminuria microvascular mmHg mmol/l myocardial infarction patients with diabetes patients with type percutaneous coronary intervention pioglitazone placebo plaque pravastatin primary QALY ramipril randomised randomized receptor renal risk factors rosiglitazone secondary prevention significant reduction simvastatin ST-segment elevation statins stents stroke subgroup symptomatic symptoms target tion treatment trial triglycerides type 2 diabetes UKPDS vascular disease vascular events